Pharmacokinetic-based Dosing Individualization of Mycophenolate Mofetil in Solid Organ Transplanted Patients
Prague Medical Report · 2024
DOI: 10.14712/23362936.2024.18 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Prague Medical Report, 2024. Verfasst von Sara Merdita und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. Hauptthemen laut MEDLINE: Mycophenolic Acid, Immunosuppressive Agents, Organ Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Zdravotnictví Ceské Republiky.
Abstract (Originalsprache)
Mycophenolate mofetil (MMF) is an immunosuppressant drug approved for prophylaxis of transplant rejection in patients undergoing solid organ transplantation and is further employed in management of various autoimmune disorders. MMF exhibits notable pharmacokinetic inter- and intraindividual variability necessitating tailored therapeutic approaches to achieve optimal therapeutic outcomes while mitigating risks of adverse effects. The objective of this review was to summarize factors that influence the pharmacokinetics of MMF and its active metabolite mycophenolic acid in order to deduce recommendations for personalized treatment strategies. Presumed predictors were analysed in relation to each of the four pharmacokinetic phases, providing tools and targets for MMF dosing optimization amenable to clinical implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. martin.sima@lf1.cuni.cz.
Förderung
- Ministerstvo Zdravotnictví Ceské Republiky
Zitieren
APA
Merdita, S., Ryšánek, P., Hartinger, J. M., Slanař, O., & Šíma, M. (2024). Pharmacokinetic-based Dosing Individualization of Mycophenolate Mofetil in Solid Organ Transplanted Patients. Prague Medical Report. https://doi.org/10.14712/23362936.2024.18
Vancouver
Merdita S, Ryšánek P, Hartinger JM, Slanař O, Šíma M. Pharmacokinetic-based Dosing Individualization of Mycophenolate Mofetil in Solid Organ Transplanted Patients. Prague Medical Report. 2024. doi:10.14712/23362936.2024.18
BibTeX
@article{Merdita2024,
author = {Merdita, Sara and Ryšánek, Pavel and Hartinger, Jan Miroslav and Slanař, Ondřej and Šíma, Martin},
title = {Pharmacokinetic-based Dosing Individualization of Mycophenolate Mofetil in Solid Organ Transplanted Patients},
journal = {Prague Medical Report},
year = {2024},
doi = {10.14712/23362936.2024.18}
}
EUVIMED